Scientific studies have shown that fiber and antioxidants can counteract the physiological effects of junk food. Groundbreaking book shows how it's done. CHICAGO , Oct. 16, 2023 /PRNewswire-PRWeb/ -- "Counteract the Fat: How Scientific ...
Cardiovascular patient community calls for change urging unhealthy cholesterol levels to be addressed as a global health priority. This announcement comes during the 2023 European Society of Cardiology (ESC) Congress, under the theme ...
SHANGHAI , June 16, 2023 /PRNewswire/ -- Cholesgen ( Shanghai ) Co.Ltd. ('Cholesgen') today announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with ...
GALWAY , Ireland , Nov. 30, 2022 /PRNewswire/ -- The Global Heart Hub has today launched its Global Cholesterol Action Plan  to reduce the impact of unhealthy cholesterol levels . Presented at their annual UNITE Summit , ...
TEL AVIV, Israel , June 21, 2022 /PRNewswire/ -- CannaLean Biotechs is happy to announce "first patient in," under its phase 2a, randomized, double-blind, placebo-controlled, multicenter clinical trial, for lowering blood cholesterol ...
SAN FRANCISCO and SUZHOU, China , April 3, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...
OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study  and positive ...
HONG KONG , Dec. 22, 2021 /PRNewswire/ -- Today , Akeso, Inc . ( 09926.HK ) announces that Ebronucimab (PCSK9 monoclonal antibody, research and development code: AK102), jointly developed by the Company and Dawnrays Biotechnology Capital ( ...
SAN FRANCISCO and SUZHOU, China , Aug. 11, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...
Launch includes announcement of Interventional Cardiologist, Dr. Heather Shenkman to join Scale's Scientific Advisory Board SHERMAN OAKS, Calif. , April 19, 2021 /PRNewswire-PRWeb/ -- 1MDâ„¢, developer of physician-formulated, ...
Over 70% of American Indian young adults (20-39 years old) and 50% of American Indian teenagers exhibit cholesterol levels or elevated blood fat, posing a risk for cardiovascular disease ...
When you accidentally stub your toe or hit your head, you're familiar with the instinct to rub the area for relief. But why does this work? Recent findings from the laboratory of Scott B. Hansen, Ph.D., illustrate how applying physical pressure on cells can diminish pain signals. Conversely, the research reveals that excessive cholesterol clusters in cell membranes may disrupt this pain-relief process. ...
Scientists have developed a groundbreaking vaccine offering a cost-effective approach to lower "bad" LDL cholesterol, responsible for perilous plaques that may obstruct blood vessels . ...
Among older adults, both elevated and reduced levels of high-density lipoprotein (HDL) cholesterol, often referred to as "good" cholesterol , are associated with a slight uptick in dementia risk, ...
A novel medicine, muvalaplin provides a ground-breaking, world’s first-ever treatment for lipoprotein(a), a predisposed form of cholesterol that raises the risk of heart attack and stroke ....
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers